General Information

Product

EGR2 Antibody

Description

Affinity Purified E3 SUMO-protein ligase EGR2 / KROX20 Antibody

Verified Applications

ELISA, IP, WB

Host

Rabbit

Species Cross Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide taken within amino acid region 60-150 on mouse E3 SUMO-protein ligase EGR2.

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

Affinity Purified

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20⁰C for long term storage

Application Protocol

ELISA

1:50,000

Immunoprecipitation

1:200

Western Blot

1:2,500-1:5,000

Protein

Uniprot #

P08152

Overview

Sequence-specific DNA-binding transcription factor. Binds to two specific DNA sites located in the promoter region of HOXA4. Binds to the promoter region of ERBB2. May play a role in the regulation of hindbrain segmentation, might act in combination with the Hox network to specify odd and even rhombomeres, and might participate in the control of the expression of some of the homeobox containing genes. E3 SUMO-protein ligase helping SUMO1 conjugation to its coregulators NAB1 and NAB2, whose sumoylation down-regulates EGR2 own transcriptional activity.

Molecular Function

chromatin binding

DNA binding

HMG box domain binding

ligase activity

metal ion binding

RNA polymerase II activating transcription factor binding

RNA polymerase II core promoter proximal region sequence-specific DNA binding

transcriptional activator activ

Subcellular Location

Nucleus

Expression

Expressed in mammary tumors (at protein level). Expressed mainly in adult thymus and embryonic nervous system.

Structure

Belongs to the EGR C2H2-type zinc-finger protein family.

Alternative Nomenclature

AT591 antibody

CMT1D antibody

CMT4E antibody

E3 SUMO-protein ligase EGR2 antibody

Early growth response 2 antibody

EGR-2 antibody

FLJ14547 antibody

KROX 20 Drosophila homolog antibody

KROX20 antibody

Zinc finger protein Krox-20 antibody

General Information

Product

AMPK alpha 1 Antibody

Description

Affinity Purified 5'-AMP-activated protein kinase catalytic subunit alpha-1 Antibody

Verified Applications

ELISA, IP, WB

Host

Rabbit

Species Cross Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide taken within amino acid region 500-550 on rat 5'-AMP-activated protein kinase catalytic subunit alpha-1 protein.

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

Affinity Purified

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20⁰C for long term storage

Application Protocol

ELISA

1:50,000

Immunoprecipitation

1:200

Western Blot

1:2,500-1:5,000

Protein

Uniprot #

P54645

Overview

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation.

Molecular Function

[acetyl-CoA carboxylase] kinase activity

[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity

AMP-activated protein kinase activity

ATP binding

chromatin binding

Subcellular Location

Nucleus, Cytoplasm

Expression

Low expression in kidney, liver, lung, heart and brain.

Structure

The AIS (autoinhibitory sequence) region shows some sequence similarity with the ubiquitin-associated domains and represses kinase activity.

Alternative Nomenclature

5 AMP activated protein kinase alpha 1catalytic subunit antibody

AAPK1 antibody

ACACA kinase antibody

acetyl CoA carboxylase kinase antibody

AMP -activate kinase alpha 1 subunit antibody

AMPK 1 antibody

AMPK alpha 1 antibody

HMG CoA reductase kinase antibody

HMGCR kinase antibody

hormone sensitive lipase kinase antibody

Hydroxymethylglutaryl CoA reductase kinase antibody

im:7154392 antibody

kinase AMPK alpha1 antibody

PRKAA 1 antibody

Protein kinase AMP activated alpha 1 catalytic subunit antibody

SNF1A antibody

Tau protein kinase PRKAA1 antibody

General Information

Product

CHMP2B Antibody

Verified Applications

ELISA, IP, WB

Host

Rabbit

Species Cross Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide taken within amino acid region 200-250 on human Vacuolar-sorting Protein SNF8 protein.

Accession #

NCBI:  NP_009172

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

Affinity Purified

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20⁰C for long term storage

Application Protocol

ELISA

1:50,000

Immunoprecipitation

1:200

Western Blot

1:2,500-1:5,000

Protein

Uniprot #

Q96H20

Overview

Component of the endosomal sorting complex required for transport II (ESCRT-II), which is required for multivesicular body (MVB) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-II complex is probably involved in the recruitment of the ESCRT-III complex. The ESCRT-II complex may also play a role in transcription regulation by participating in derepression of transcription by RNA polymerase II, possibly via its interaction with ELL. Required for degradation of both endocytosed EGF and EGFR, but not for the EGFR ligand-mediated internalization. It is also required for the degradation of CXCR4. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).

Molecular Function

channel regulator activity

protein C-terminus binding

protein homodimerization activity

protein N-terminus binding

transcription factor binding

Subcellular Location

Endosome membrane

Late endosome membrane

Expression

Component of the endosomal sorting complex required for transport II (ESCRT-II), composed of SNF8, VPS25 and VPS36. SNF8 is essential for the stability of the ESCRT-II complex. ESCRT-II interacts with ELL. Interacts with TSG101 (via the C-terminal domain). Interacts with RILPL1 (via the N-terminal domain); which recruits ESCRT-II to the endosome membranes. Interacts with 14-3-3 proteins.

Structure

Belongs to the SNF8 family.

Alternative Nomenclature

ALS17 antibody

Charged multivesicular body protein 2b antibody

CHM2B_HUMAN antibody

CHMP family, member 2B antibody

CHMP2.5 antibody

CHMP2b antibody

Chromatin modifying protein 2b antibody

DMT1 antibody

hVps2-2 antibody

Vacuolar protein sorting 2, yeast, homolog of, B antibody

Vacuolar protein sorting 2-2 antibody

Vacuolar protein sorting-associated protein 2-2 antibody

VPS2 homolog B antibody

Vps2-2 antibody

VPS2B antibody

General Information

Product

GBA Antibody

Description

Affinity Purified Glucosylceramidase Antibody

Verified Applications

ELISA, IHC, IP, WB

Host

Rabbit

Species Cross Reactivity

Human, Mouse

Immunogen

Recombinant Glucosylceramidase protein.

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

Affinity Purified

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20⁰C for long term storage

Application Protocol

ELISA

1:50,000

Immunoprecipitation

1:200

Western Blot

1:2,500-1:5,000

Protein

Uniprot #

P04062

Overview

Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose (PubMed:9201993, PubMed:24211208). Thereby, plays a central role in the degradation of complex lipids and the turnover of cellular membranes (PubMed:27378698). Through the production of ceramides, participates to the PKC-activated salvage pathway of ceramide formation (PubMed:19279011). Also plays a role in cholesterol metabolism (PubMed:24211208, PubMed:26724485). May either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol (PubMed:24211208, PubMed:26724485). The short chain saturated C8:0-GlcCer and the mono-unsaturated C18:0-GlcCer being the most effective glucose donors for that transglucosylation reaction (PubMed:24211208). Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl-beta-D-glucoside to ceramide (PubMed:26724485). Finally, may also hydrolyze cholesteryl-beta-D-glucoside to produce D-glucose and cholesterol (PubMed:24211208, PubMed:26724485).

Molecular Function

glucosylceramidase activity

glucosyltransferase activity

hydrolase activity

scavenger receptor binding

signaling receptor binding

steryl-beta-glucosidase activity

Subcellular Location

Lysosome

Expression

Interacts with saposin-C (PubMed:10781797). Interacts with SCARB2 (PubMed:18022370). Interacts with TCP1 (PubMed:21098288). May interact with SNCA; may inhibit the glucosylceramidase activity (PubMed:23266198). Interacts with GRN; this interaction prevents aggregation of GBA-SCARB2 complex via interaction with HSPA1A upon stress (PubMed:27789271).

Structure

Belongs to the glycosyl hydrolase 30 family.

Alternative Nomenclature

Lysosomal acid glucosylceramidase

General Information

Product

HYPE Antibody

Description

Affinity Purified Protein adenylyltransferase FICD Antibody

Verified Applications

ELISA, IP, WB

Host

Rabbit

Species Cross Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide corresponding to amino acids within region 400-450 on mouse Protein adenylyltransferase FICD.

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

Affinity Purified

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20?C for long term storage

Application Protocol

ELISA

1:50,000

Immunoprecipitation

1:200

Western Blot

1:500-1:5,000

Protein

Uniprot #

Q9BVA6

Overview

Protein that can both mediate the addition of adenosine 5'-monophosphate (AMP) to specific residues of target proteins (AMPylation), and the removal of the same modification from target proteins (de-AMPylation), depending on the context (By similarity). The side chain of Glu-231 determines which of the two opposing activities (AMPylase or de-AMPylase) will take place (By similarity).

Molecular Function

ATP binding

chaperone binding

Hsp70 protein binding

identical protein binding

protein adenylylhydrolase activity

protein adenylyltransferase activity

protein homodimerization activity

Subcellular Location

Endoplasmic reticulum

Expression

Ubiquitous.

Alternative Nomenclature

Adenosine monophosphate-protein transferase FICD antibody

AMPylator FICD antibody

FIC domain containing antibody

FIC domain containing protein antibody

Fic S phase protein cell division homolog antibody

ficd antibody

FICD_HUMAN antibody

HIP-13 antibody

HIP13 antibody

Huntingtin interacting protein 13 antibody

Huntingtin interacting protein E antibody

Huntingtin yeast partner E antibody

MGC5623 antibody

UNQ3041 antibody